6.
Villanueva-Meyer J, Mabray M, Cha S
. Current Clinical Brain Tumor Imaging. Neurosurgery. 2017; 81(3):397-415.
PMC: 5581219.
DOI: 10.1093/neuros/nyx103.
View
7.
Salmi L, Lum H, Hayden A, Reblin M, Otis-Green S, Venechuk G
. Stakeholder engagement in research on quality of life and palliative care for brain tumors: a qualitative analysis of #BTSM and #HPM tweet chats. Neurooncol Pract. 2020; 7(6):676-684.
PMC: 7716141.
DOI: 10.1093/nop/npaa043.
View
8.
Moura C, Vale N
. The Role of Dopamine in Repurposing Drugs for Oncology. Biomedicines. 2023; 11(7).
PMC: 10377204.
DOI: 10.3390/biomedicines11071917.
View
9.
Hardy S, Finkelstein A, Milano M, Schifitto G, Sun H, Holley K
. Association of Radiation Dose to the Amygdala-Orbitofrontal Network with Emotion Recognition Task Performance in Patients with Low-Grade and Benign Brain Tumors. Cancers (Basel). 2023; 15(23).
PMC: 10705220.
DOI: 10.3390/cancers15235544.
View
10.
Shah V, Kochar P
. Brain Cancer: Implication to Disease, Therapeutic Strategies and Tumor Targeted Drug Delivery Approaches. Recent Pat Anticancer Drug Discov. 2017; 13(1):70-85.
DOI: 10.2174/1574892812666171129142023.
View
11.
Zwinkels H, Dirven L, Vissers T, Habets E, Vos M, Reijneveld J
. Prevalence of changes in personality and behavior in adult glioma patients: a systematic review. Neurooncol Pract. 2019; 3(4):222-231.
PMC: 6657393.
DOI: 10.1093/nop/npv040.
View
12.
Caragher S, Hall R, Ahsan R, Ahmed A
. Monoamines in glioblastoma: complex biology with therapeutic potential. Neuro Oncol. 2017; 20(8):1014-1025.
PMC: 6280144.
DOI: 10.1093/neuonc/nox210.
View
13.
Yen C, Lin C, Chiang M
. Exploring the Frontiers of Neuroimaging: A Review of Recent Advances in Understanding Brain Functioning and Disorders. Life (Basel). 2023; 13(7).
PMC: 10381462.
DOI: 10.3390/life13071472.
View
14.
Campanella F, Fabbro F, Ius T, Shallice T, Skrap M
. Acute effects of surgery on emotion and personality of brain tumor patients: surgery impact, histological aspects, and recovery. Neuro Oncol. 2015; 17(8):1121-31.
PMC: 4490877.
DOI: 10.1093/neuonc/nov065.
View
15.
Lange M, Clarisse B, Leconte A, Dembele K, Lequesne J, Nicola C
. Cognitive assessment in patients treated by immunotherapy: the prospective Cog-Immuno trial. BMC Cancer. 2022; 22(1):1308.
PMC: 9749352.
DOI: 10.1186/s12885-022-10384-y.
View
16.
Renovanz M, Hippler M, Voss M, Wehinger J, Kessler A, Gempt J
. Glioma patients in outpatient care-optimization of psychosocial care in neuro-oncological patients (GLIOPT): Protocol for a cluster randomized controlled trial. Trials. 2020; 21(1):434.
PMC: 7251889.
DOI: 10.1186/s13063-020-04321-2.
View
17.
Tsuboi D, Nagai T, Yoshimoto J, Kaibuchi K
. Neuromodulator regulation and emotions: insights from the crosstalk of cell signaling. Front Mol Neurosci. 2024; 17:1376762.
PMC: 10954900.
DOI: 10.3389/fnmol.2024.1376762.
View
18.
Qin D, Du W, Sha S, Parkinson A, Glasgow N
. Hospital psychosocial interventions for patients with brain functional impairment: A retrospective cohort study. Int J Ment Health Nurs. 2019; 28(5):1152-1161.
DOI: 10.1111/inm.12627.
View
19.
Simpson G, Koh E, Whiting D, Wright K, Simpson T, Firth R
. Frequency, clinical correlates, and ratings of behavioral changes in primary brain tumor patients: a preliminary investigation. Front Oncol. 2015; 5:78.
PMC: 4381693.
DOI: 10.3389/fonc.2015.00078.
View
20.
Liang S, Liu H, Lu Y, Wu S, Chien C, Tsay S
. The Influence of Resilience on the Coping Strategies in Patients with Primary Brain Tumors. Asian Nurs Res (Korean Soc Nurs Sci). 2020; 14(1):50-55.
DOI: 10.1016/j.anr.2020.01.005.
View